LenioBio GmbH, based in Düsseldorf, is a biopharmaceutical brand that is redefining the manufacturing process in the industry. Their mission is to provide every person with an equal chance to lead a healthy life by developing innovative solutions for untreatable diseases and improving access to medicines. One of their groundbreaking technologies is ALiCE®, a cell-free protein production platform that eliminates the need for traditional cell-line and upstream process development.

With ALiCE®, proteins can be produced rapidly, regardless of their complexity, scale, or compatibility with existing processes. It offers plug-and-play convenience and can be easily integrated into research projects. LenioBio also offers an end-to-end protein service for research-grade protein expression.

From cloning to expression and purification, they enable customers to unlock new potential without utilizing their own resources. Their disruptive approach to biomanufacturing aims to simplify the process and accelerate the delivery of life-saving drugs to patients. Join LenioBio in their mission to make medicines accessible to all